title: Biotyping and susceptibility behaviour of pathogens in patients treated with ciprofloxacin.
authors.affiliation: Pharma Research Center, Bayer AG, D-5600 Wuppertal 1, FRG.
authors.forename: C
authors.initials: C
authors.lastname: Krasemann
authors.forename: H
authors.initials: H
authors.lastname: Von Poppel
authors.forename: M
authors.initials: M
authors.lastname: Wegge
authors.forename: V
authors.initials: V
authors.lastname: Chysky
mesh_terms: D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use*; D018849:Controlled Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy / Q000382:microbiology*; D014552:Urinary Tract Infections / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin